T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Humana
HUM
|
+$2.39B |
| 2 |
UnitedHealth
UNH
|
+$1.47B |
| 3 |
GE Aerospace
GE
|
+$1.33B |
| 4 |
Amazon
AMZN
|
+$1.18B |
| 5 |
AbbVie
ABBV
|
+$1.13B |
Top Sells
| 1 |
Boeing
BA
|
+$1.56B |
| 2 |
Nike
NKE
|
+$1.42B |
| 3 |
Becton Dickinson
BDX
|
+$1.33B |
| 4 |
Alibaba
BABA
|
+$1.23B |
| 5 |
JPMorgan Chase
JPM
|
+$1.22B |
Sector Composition
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
901
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $34.6M | 0.01% |
548,882
-100,102
| -15% | -$6.3M |
|
902
Tetra Tech
TTEK
$9.51B
| $34.4M | 0.01% |
2,433,420
+258,080
| +12% | +$3.65M |
|
903
Alcoa
AA
$8.36B
| $34.3M | 0.01% |
5,574,374
+5,505,519
| +7,996% | +$33.9M |
|
904
i3 Verticals
IIIV
$744M
| $34.3M | 0.01% |
1,796,307
+150,064
| +9% | +$2.86M |
|
905
Employers Holdings
EIG
$996M
| $34.3M | 0.01% |
845,698
+564
| +0.1% | +$22.8K |
|
906
Federal Signal
FSS
$7.77B
| $34.1M | 0.01% |
1,249,507
+713,966
| +133% | +$19.5M |
|
907
Zymeworks
ZYME
$1.24B
| $34.1M | 0.01% |
960,406
+85,843
| +10% | +$3.04M |
|
908
Frontdoor
FTDR
$4.9B
| $33.7M | 0.01% |
969,119
-21,877
| -2% | -$761K |
|
909
CMS Energy
CMS
$21.5B
| $33.6M | 0.01% |
571,489
+41,219
| +8% | +$2.42M |
|
910
Apellis Pharmaceuticals
APLS
$3.21B
| $33.5M | 0.01% |
1,250,870
+459,207
| +58% | +$12.3M |
|
911
International Seaways
INSW
$2.32B
| $33.2M | 0.01% |
1,389,158
+234,785
| +20% | +$5.61M |
|
912
Nasdaq
NDAQ
$55B
| $33.1M | 0.01% |
1,044,375
-109,236
| -9% | -$3.46M |
|
913
XPO
XPO
$15.8B
| $33M | 0.01% |
1,956,540
+19,578
| +1% | +$330K |
|
914
Manhattan Associates
MANH
$13.3B
| $33M | 0.01% |
662,089
+2,131
| +0.3% | +$106K |
|
915
Onto Innovation
ONTO
$5.3B
| $32.9M | 0.01% |
1,109,555
-67,301
| -6% | -$2M |
|
|
ORTX
916
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $32.8M | 0.01% |
435,670
-111,276
| -20% | -$8.38M |
|
917
Novartis
NVS
$247B
| $32.7M | 0.01% |
396,716
+304,665
| +331% | +$25.1M |
|
918
Schrodinger
SDGR
$1.38B
| $32.6M | 0.01% |
+755,085
| New | +$32.6M |
|
919
Hormel Foods
HRL
$14B
| $32.3M | 0.01% |
692,208
+39,824
| +6% | +$1.86M |
|
|
RST
920
DELISTED
ROSETTA STONE INC
RST
| $32.1M | 0.01% |
2,291,832
+94,558
| +4% | +$1.33M |
|
|
CMO
921
DELISTED
Capstead Mortgage Corp.
CMO
| $32M | 0.01% |
7,626,956
+87,049
| +1% | +$366K |
|
922
Huntsman Corp
HUN
$1.94B
| $31.8M | 0.01% |
2,204,528
+2,086,102
| +1,762% | +$30.1M |
|
923
ASGN Inc
ASGN
$2.33B
| $31.7M | 0.01% |
898,819
-121,777
| -12% | -$4.3M |
|
924
Tandem Diabetes Care
TNDM
$864M
| $31.7M | 0.01% |
493,159
+236,324
| +92% | +$15.2M |
|
925
BellRing Brands
BRBR
$4.7B
| $31.7M | 0.01% |
1,858,960
-2,122,301
| -53% | -$36.2M |
|